Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail
-

Public Calendar: February 23-29, 2009

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Frank Torti, Acting Commissioner 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Randall Lutter, Deputy Commissioner for Policy 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs 2/24/09 Rockville, Maryland David Elder, George Salem, Richard Garwood Susan de Mars, Roger L. Williams, Brian Hendrix, Ken Alexander, Steve Lane (USP) Discuss the CRADA between FDA and USP
Jesse Goodman, Director, Center for Biologics Evaluation and Research 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
William Slikker, Director, National Center for Toxicological Research 2/23/09 through 2/27/09 N/A N/A N/A No significant meetings
Jeffrey M. Senger, Acting Chief Counsel 2/25/2009 FDA/Rockville Kim Dettelbach, Julie Finegan, Eric Blumberg (OCC) Robert Dormer, Michelle Butler (Hyman, Phelps & McNamara) ANDA Approval Issues

 

 

-
-